(VIANEWS) – The NYSE opens in less than one hour and Thermo Fisher Scientific‘s pre-market value is already 4.65% down.
Thermo Fisher Scientific’s last close was $544.32, 10.75% under its 52-week high of $609.85.
The last session, NYSE ended with Thermo Fisher Scientific (TMO) sliding 0.31% to $544.32. NYSE jumped 0.11% to $16,799.54, following the last session’s upward trend on what was a somewhat bullish trend exchanging session.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Earnings Per Share
As for profitability, Thermo Fisher Scientific has a trailing twelve months EPS of $15.24.
PE Ratio
Thermo Fisher Scientific has a trailing twelve months price to earnings ratio of 35.72. Meaning, the purchaser of the share is investing $35.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
Moving Average
Thermo Fisher Scientific’s value is higher than its 50-day moving average of $498.60 and above its 200-day moving average of $520.38.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 0.26%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 4.4% and a drop 0.8% for the next.
More news about Thermo Fisher Scientific (TMO).
